Set of genes predicts severity of dengue
SPARK team identifies 20 genes that can predict an individual’s likelihood of developing a severe form of dengue fever with ~80 percent accuracy.
Read PostCategory: News
SPARK Profiled by ABC News
In developing new drugs for rare diseases, this non-profit steps in when pharmaceutical companies won't
Read Post
Sparking drug discoveries
Stanford Medicine Magazine profiles SPARK and Dr. Jane Tseng's work
Read Post
Innovators SPARKle at Stanford University Event for Investors
SPARK and Oppenheimer & Co. cohosted a summit for emerging biotech science with presentations from a few SPARK projects.
Read Post
SPARK bestows 4th SPARK Excellence Award
SPARKee, Christopher Mount, PhD, receives the fourth SPARK Excellence Award for his therapy for diffuse intrinsic pontine glioma.
Read Post
SPARK Stanford Discusses Crossing the Valley of Death with Universities in Taiwan
In May of 2018, SPARK participated in a conference on pharmaceutical and medical device development
Read Post
SPARK Global Drug Development Course Taught in Brazil
Dr. Monica Marcolino reflects on her experiences teaching drug development to students in Brazil.
Read Post
SPARK spinout raises $64 million
Eidos Therapeutics, a subsidiary of Biobridge Pharma, raises $64 million in Series B financing round to further develop their treatment candidate for transthyretin amyloidosis.
Read Post
Innovating Together
Universities start program to accelerate growth of research-based companies in the health sector. (About SPARK Finland.)
Read Post